全文获取类型
收费全文 | 3226篇 |
免费 | 160篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 105篇 |
妇产科学 | 8篇 |
基础医学 | 355篇 |
口腔科学 | 68篇 |
临床医学 | 411篇 |
内科学 | 964篇 |
皮肤病学 | 33篇 |
神经病学 | 65篇 |
特种医学 | 59篇 |
外科学 | 332篇 |
综合类 | 314篇 |
预防医学 | 257篇 |
眼科学 | 104篇 |
药学 | 201篇 |
3篇 | |
中国医学 | 26篇 |
肿瘤学 | 77篇 |
出版年
2023年 | 48篇 |
2022年 | 108篇 |
2021年 | 164篇 |
2020年 | 169篇 |
2019年 | 130篇 |
2018年 | 146篇 |
2017年 | 117篇 |
2016年 | 90篇 |
2015年 | 96篇 |
2014年 | 222篇 |
2013年 | 219篇 |
2012年 | 193篇 |
2011年 | 199篇 |
2010年 | 145篇 |
2009年 | 136篇 |
2008年 | 119篇 |
2007年 | 116篇 |
2006年 | 102篇 |
2005年 | 115篇 |
2004年 | 92篇 |
2003年 | 77篇 |
2002年 | 58篇 |
2001年 | 51篇 |
2000年 | 46篇 |
1999年 | 49篇 |
1998年 | 33篇 |
1997年 | 38篇 |
1996年 | 36篇 |
1995年 | 41篇 |
1994年 | 30篇 |
1993年 | 25篇 |
1992年 | 31篇 |
1991年 | 15篇 |
1990年 | 19篇 |
1989年 | 12篇 |
1988年 | 18篇 |
1987年 | 11篇 |
1986年 | 19篇 |
1985年 | 19篇 |
1984年 | 15篇 |
1983年 | 9篇 |
1982年 | 10篇 |
1981年 | 13篇 |
1980年 | 6篇 |
1979年 | 7篇 |
1978年 | 7篇 |
1977年 | 3篇 |
1976年 | 4篇 |
1975年 | 1篇 |
1974年 | 2篇 |
排序方式: 共有3432条查询结果,搜索用时 31 毫秒
1.
2.
《Clinical microbiology and infection》2022,28(8):1120-1125
ObjectivesOur aim was to evaluate the effect of the updated European Organization for Research and Treatment of Cancer (EORTC) and Mycoses Study Group 2019 definitions for invasive pulmonary aspergillosis (IPA) on patient classification and the related all-cause 12-week mortality.MethodsIn this retrospective cohort study from our tertiary care centre, we reclassified patients with haematological malignancy who underwent bronchoalveolar lavage between 2014 and 2019 for suspected IPA using the novel EORTC 2019 criteria. We performed receiver operating characteristic curve analysis to define the optimal cut-off for positive PCR and galactomannan and present survival analyses and their possible association with these diagnostic criteria through post hoc comparisons with log rank and Cox regression.ResultsFrom 323 episodes of suspected IPA in 282 patients, 73 were reclassified: 31 (42.5%) from possible to probable IPA, 5 (6.8%) from EORTC criteria not met to probable IPA, and 37 (50.7%) from EORTC criteria not met to possible IPA. Probable IPA increased therefore 11.1% (64/323, 19.8% to 100/323, 30.9%), mostly due to positive PCR (31/36, 86.1%). There was no difference in mortality between newly defined possible and probable IPA (log rank p = 0.950). Mortality was higher in probable cases with lower cycle thresholds (Ct values) versus higher Ct values (p = 0.004). Receiver operating characteristic curve analysis showed an optimal Ct value cut-off of 36.8 with a sensitivity of 75% (95% CI 64.9%–85.1%) and a specificity of 61.7% (95% CI 53.5–69.9) for 12-week mortality.DiscussionThe new EORTC criteria led to 11.1% more probable IPA diagnoses, mostly due to Aspergillus PCR. Restricting positive PCR to below a certain threshold might improve the discrimination of the new EORTC IPA categories for mortality. 相似文献
3.
4.
《Indian heart journal》2022,74(3):163-169
BackgroundInfective endocarditis patients present very rarely with vegetations on the mural endocardium. Only very few studies are available comparing Mural infective endocarditis with commoner valvular or device related infective endocarditis.AimTo analyse the clinical features, microbiological profile and clinical course of mural endocarditis in comparison to valvular endocarditis.MethodsThis was a retrospective analysis of data from a registry of infective endocarditis. Patients enrolled between April 2012 and April 2019 were included. Patients who were reported to have vegetations on the mural endocardial surface were taken as a group and compared with rest of the patients. Clinical profile, laboratory parameters including culture and outcomes were compared between the two groups.ResultsOut of 278 patients in the study, 15 (5.38%) had vegetations on the mural endocardium. Of them, only 4 patients had structural heart diseases. All the patients with mural endocarditis were NYHA class II or below at presentation. Ventricles were the commonest sites of vegetations. Inflammatory markers like ESR and CRP were low in mural endocarditis compared to rest. Culture positivity was high in mural endocarditis and Staphylococcus Aureus was the commonest organism. Mural endocarditis patients had similar in hospital mortality to rest of the patients. Cardiac complications were not reported in mural endocarditis, but they had similar incidence of embolic complications including neurological events.ConclusionMural endocarditis is a rare clinical entity with similar morbidity and mortality to that of endocarditis with valvular vegetation. 相似文献
5.
6.
7.
8.
9.
《Vaccine》2021,39(30):4099-4107
The fungal genus Candida includes common commensals of the human mucosal membranes, and the most prevalently isolated species, C. albicans, poses a threat of candidemia and disseminated infection associated with an unacceptably high mortality rate and an immense $4 billion burden (US) yearly. Nevertheless, the demand for a vaccine remains wholly unfulfilled and increasingly pressing. We developed a double-peptide construct that is feasible for use in humans with the intention of preventing morbid infection by targeting epitopes derived from fructose bisphosphate aldolase (Fba) and methionine synthase (Met6) which are expressed on the C. albicans cell surface. To test the applicability of the design, we vaccinated mice via the intramuscular (IM) route with the conjugate denoted Fba-Met6 MP12 and showed that the vaccine enhanced survival against a lethal challenge. Because overall endpoint IgG1 and IgG2a antibody titers were robust and these mouse subclasses are associated with protective functionality, we investigated the potential of Fba and Met6 specific antibodies to facilitate the well-defined anti-Candida response by complement, which opsonizes fungi for degradation by primary effectors. Notably, reductions in the fungal burdens and enhanced survival were both abrogated in MP12-vaccinated mice that were pre-challenge dosed with cobra venom factor (CVF), a complement depleting factor. Altogether, we demonstrated that complement is relevant to MP12-based protection against disseminated C. albicans, delineating that a novel, multivalent targeted vaccine against proteins on the surface of C. albicans can enhance the natural response to infection. 相似文献
10.
Christopher J. Destache David J. Guervil Keith S. Kaye 《International journal of antimicrobial agents》2019,53(5):644-649